Molecular and Genetic Basis of Neuropathology

1. Introduction to Molecular and Genetic Neuropathology:
- Definition and scope
- Historical perspective and recent advances
2. Basic Genetic Concepts in Neuropathology:
a) DNA structure and function
b) Gene expression and regulation
c) Mutations: types and consequences
d) Inheritance patterns
e) Epigenetics in neuropathology
3. Molecular Mechanisms in Neuropathology:
a) Protein misfolding and aggregation
b) Oxidative stress and mitochondrial dysfunction
c) Neuroinflammation
d) Apoptosis and neuronal death
e) Synaptic dysfunction
f) Axonal transport defects
g) Neurotransmitter imbalances
4. Genetic Basis of Neurodevelopmental Disorders:
a) Autism Spectrum Disorders
b) Intellectual Disability
c) Schizophrenia
d) Attention Deficit Hyperactivity Disorder (ADHD)
5. Genetics of Neurodegenerative Diseases:
a) Alzheimer's Disease:
- APP, PSEN1, PSEN2 mutations
- APOE ε4 allele as a risk factor
b) Parkinson's Disease:
- SNCA, LRRK2, Parkin, PINK1 mutations
c) Huntington's Disease:
- HTT gene CAG repeat expansion
d) Amyotrophic Lateral Sclerosis (ALS):
- SOD1, C9ORF72, FUS, TARDBP mutations
e) Frontotemporal Dementia:
- MAPT, GRN, C9ORF72 mutations
6. Genetic Basis of Neuromuscular Disorders:
a) Duchenne and Becker Muscular Dystrophies
b) Spinal Muscular Atrophy
c) Charcot-Marie-Tooth Disease
7. Molecular Pathology of Brain Tumors:
a) Gliomas: IDH mutations, 1p/19q codeletion
b) Medulloblastomas: WNT and SHH pathway alterations
c) Meningiomas: NF2 mutations
8. Genetic Basis of Epilepsy:
a) Monogenic epilepsies (e.g., SCN1A mutations in Dravet syndrome)
b) Complex inheritance in common epilepsies
9. Molecular Mechanisms in Cerebrovascular Diseases:
a) CADASIL (NOTCH3 mutations)
b) Cerebral amyloid angiopathy
10. Genetic Risk Factors in Psychiatric Disorders:
a) Major Depressive Disorder
b) Bipolar Disorder
c) Obsessive-Compulsive Disorder
11. Molecular Techniques in Neuropathology:
a) PCR and DNA sequencing
b) FISH and karyotyping
c) Microarrays and RNA-seq
d) Proteomics
e) CRISPR-Cas9 gene editing
f) Single-cell sequencing
g) Genome-wide association studies (GWAS)
12. Animal Models in Molecular Neuropathology:
a) Transgenic mice
b) Knock-out and knock-in models
c) Drosophila and C. elegans models
d) Induced Pluripotent Stem Cells (iPSCs)
13. Emerging Concepts:
a) RNA-mediated neuropathology
b) Prion-like spread of protein aggregates
c) Mitochondrial DNA mutations in neurodegeneration
d) Somatic mosaicism in brain disorders
e) Circular RNAs in neuropathology
14. Therapeutic Approaches Based on Molecular Insights:
a) Gene therapy
b) Antisense oligonucleotides
c) Small molecule drugs targeting specific pathways
d) Immunotherapies
e) Stem cell therapies
15. Pharmacogenomics in Neurological Disorders:
- Genetic factors influencing drug response and side effects
16. Genetic Counseling in Neurological Disorders:
- Ethical considerations
- Predictive testing
17. Future Directions:
a) Personalized medicine in neuropathology
b) Integration of multi-omics data
c) Artificial intelligence in genetic data analysis
d) Gene editing as a therapeutic approach
18. Challenges in Molecular and Genetic Neuropathology:
- Complexity of brain function and disease
- Heterogeneity within disease categories
- Translating genetic findings into clinical applications
19. Ethical Considerations:
- Genetic testing and privacy
- Gene editing in humans
- Handling incidental findings in genetic studies